Evidence map›Paper›PMID 36584229›Full record

ArticlePloS one2022

Feasibility of a novel ultra-low-cost bubble CPAP (bCPAP) System for neonatal respiratory support at Muhimbili National Hospital, Tanzania.

Ashtyn Tayler, Henry Ashworth, Ghassan Bou Saba, Hena Wadhwa, Michelle Dundek, Ellie Ng, Kennedy Opondo, Martha Mkony, Robert Moshiro, Thomas Burke

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ashtyn TaylerVayu Global Health Foundation, Boston, MA, United States of America.ORCID 0000-0002-5045-521X
Henry AshworthVayu Global Health Foundation, Boston, MA, United States of America.ORCID 0000-0002-8989-8560
Ghassan Bou SabaVayu Global Health Foundation, Boston, MA, United States of America.
Hena WadhwaVayu Global Health Foundation, Boston, MA, United States of America.
Michelle DundekVayu Global Health Foundation, Boston, MA, United States of America.
Ellie NgVayu Global Health Foundation, Boston, MA, United States of America.
Kennedy OpondoVayu Global Health Foundation, Boston, MA, United States of America.
Martha MkonyMuhimbili National Hospital, Dar es Salaam, Tanzania.
Robert MoshiroMuhimbili National Hospital, Dar es Salaam, Tanzania.
Thomas BurkeVayu Global Health Foundation, Boston, MA, United States of America.
Harvard University · USMuhimbili University of Health and Allied Sciences · TZMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveContinuous Positive Airway Pressure (CPAP) is recommended in the treatment of respiratory distress syndrome of premature newborns, however there are significant barriers to its implementation in low-resource settings. The objective of this study was to evaluate the feasibility of use and integration of Vayu bCPAP Systems into the newborn unit at Muhimbili National Hospital in Tanzania. STUDY

designA prospective qualitative study was conducted from April 6 to October 6 2021. Demographic and clinical characteristics of patients treated with Vayu bCPAP Systems were collected and analyzed. Healthcare workers were interviewed until thematic saturation. Interviews were transcribed, coded, and analyzed using a framework analysis.

results370 patients were treated with Vayu bCPAP Systems during the study period. Mean birth weight was 1522 g (500-3800), mean duration of bCPAP treatment was 7.2 days (<1-39 d), and survival to wean was 81.4%. Twenty-four healthcare workers were interviewed and perceived Vayu bCPAP Systems as having become essential for treating neonatal respiratory distress at MNH. Key reasons were that Vayu bCPAP Systems improve patient outcomes, are easy to use, and more patients are now able to receive quality care. Barriers to integration included durability of oxygen tubing material and training.

conclusionsIt was feasible to implement and integrate Vayu bCPAP Systems into the care of neonates at Muhimbili National Hospital.

Indexed as

Continuous Positive Airway PressureRespiratory Distress Syndrome, NewbornFeasibility StudiesHospitalsHumansInfant, NewbornProspective StudiesTanzaniaTreatment Outcome

Identifiers

PMID36584229
PMCPMC9803298
OpenAlexW4313306872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.